trending Market Intelligence /marketintelligence/en/news-insights/trending/hmvxsvudrtumpuekd73yug2 content esgSubNav
In This List

Chembio Diagnostics appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Chembio Diagnostics appoints director

Chembio Diagnostics Inc. appointed John Potthoff to its board.

Potthoff is the CEO of Elligo Health Research Inc., a clinical research company in Austin, Texas.

Medford, N.Y.-based Chembio Diagnostics develops point-of-care diagnostic tests that are used to detect or monitor diseases.